Experimental and Clinical Endocrinology & Diabetes

Issue S 02 · Volume 106 · 1998 DOI: 10.1055/s-002-19248

Session 1: Obesity: the most extensive non-communicable disease of the 21st century

Philip, W.; James, T.: What are the health risks? The medical consequences of obesity and its health risks

Full Text
PDF (190 kb)

Seidell, J. C.: Societal and personal costs of obesity

Full Text
PDF (53 kb)

de Leiva, A.: What are the benefits of moderate weight loss?

Full Text
PDF (66 kb)

Williamson, D. F.: Weight loss and mortality in persons with type-2 diabetes mellitus: a review of the epidemiological evidence

Full Text
PDF (145 kb)

Lean, M. E. J.: Obesity — what are the current treatment options?

Full Text
PDF (154 kb)

Session 2: The place of sibutramine in clinical practice

Rössner, S.: Obesity - as seen by the patient and his family

Full Text
PDF (54 kb)

Astrup, A.; Lundsgaard, C.: What do pharmacological approaches to obesity management offer? Linking pharmacological mechanisms of obesity management agents to clinical practice

Full Text
PDF (101 kb)

Van Gaal, L. F.; Wauters, M. A.; De Leeuw, I. H.: Anti-obesity drugs: what does sibutramine offer? An analysis of its potential contribution to obesity treatment

Full Text
PDF (144 kb)